Quest Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-84,154
Closed -$17.7M 107
2016
Q4
$17.7M Buy
84,154
+25,347
+43% +$5.25M 2.26% 7
2016
Q3
$13.5M Buy
58,807
+409
+0.7% +$99.9K 1.78% 31
2016
Q2
$13.5M Buy
58,398
+4,529
+8% +$1.04M 1.84% 24
2016
Q1
$14.4M Buy
53,869
+7,456
+16% +$2.13M 1.99% 14
2015
Q4
$14.5M Sell
46,413
-3,038
-6% -$904K 1.97% 12
2015
Q3
$13.4M Buy
49,451
+10,498
+27% +$3.22M 1.88% 6
2015
Q2
$11.8M Buy
38,953
+1,360
+4% +$406K 1.66% 9
2015
Q1
$11.2M Buy
+37,593
New +$10.7M 1.52% 18

Other funds holding AGN

Quest Investment Management's AGN Position: Q1 2017 in Review

Quest Investment Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 84,154 shares — an estimated $17.7M sold.

Quest Investment Management first reported a position in AGN in Q1 2015 and held it in 8 quarters. The position peaked at $17.7M in Q4 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Quest Investment Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Quest Investment Management sold 84,154 Allergan plc shares in Q1 2017, an estimated $17.7M.
  • Quest Investment Management first reported a position in Allergan plc in Q1 2015 and held it in 8 quarters.
  • Quest Investment Management's Allergan plc position peaked at $17.7M in Q4 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Quest Investment Management's 13F filing for Q1 2017, filed 12 May 2017.